Related Experiment Video
Updated: Jul 27, 2025
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Childhood granulomatous periorificial dermatitis in 31 Chinese children successfully treated with oral roxithromycin
Senfen Wang1, Ping Li1, Jianhong Li1
1Department of Dermatology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Insights
Oral roxithromycin effectively treats childhood granulomatous periorificial dermatitis (CGPD). In a study of 31 children, 90.3% recovered with no severe side effects after 12 weeks.
Area of Science:
- Dermatology
- Pediatrics
- Pharmacology
Background:
- Limited data exists on oral therapies for childhood granulomatous periorificial dermatitis (CGPD).
- CGPD requires effective and safe treatment options for pediatric patients.
Purpose of the Study:
- To evaluate the efficacy and safety of oral roxithromycin for treating CGPD in children.
- To assess treatment outcomes and adverse effects of roxithromycin in pediatric CGPD cases.
Main Methods:
- A study involving 31 Chinese children diagnosed with CGPD.
- Treatment administered was oral roxithromycin over a 12-week period.
- Outcomes measured included patient recovery rates and incidence of adverse effects.
Main Results:
- A high recovery rate of 90.3% was observed among the treated children.
- No severe adverse effects were reported during the 12-week treatment course.
- Oral roxithromycin demonstrated significant therapeutic benefits for CGPD.
Conclusions:
- Oral roxithromycin is a safe and effective treatment for childhood granulomatous periorificial dermatitis.
- The study supports the use of roxithromycin as a viable therapeutic option for pediatric CGPD.
Abstract:
Data regarding the treatment of childhood granulomatous periorificial dermatitis (CGPD) using oral therapies are limited. This study included 31 Chinese children with CGPD treated with oral roxithromycin. After 12 weeks of treatment, 90.3% of the patients recovered, and there were no severe adverse effects. Our results suggest that oral roxithromycin is an effective and safe treatment for CGPD.
